baber/WOPTO huggingface dataset:
Patent CA-3049124-A1 (CA)
Inventor: GOODMAN PAUL D
IPC: A61F2/07
Filed: 2018-01-25
Abstract: Various aspects of the present disclosure are directed toward apparatuses, systems and methods that include arranging an implantable flow restriction device within the aorta of a patient. The methods may also include physical dimensions of the implantable flow restriction device.
Patent CA-3049517-A1 (CA)
Inventor: WEE GUSTAV
IPC: F03B13/26
Filed: 2016-11-11
Abstract: An offshore power generating assembly comprising a floating unit (1), at least one generator (3), a base (4) connected to the seabed below the floating unit and a number of cylinders (5) comprising a pair of cylinder spindles (10). The cylinders are connected to the floating unit and the base, so that fluid is compressed by the cylinders during tidal changes. The compressed fluid provide power to the at least one generator (3).
Patent CA-3051170-A1 (CA)
Inventor: HOLMES TIMOTHY ANDREW
IPC: G06Q10/06
Filed: 2017-03-15
Abstract: L'invention concerne des systèmes et des procédés pour déterminer si la sortie d'une première application doit être interrompue par la sortie d'une seconde application. L'application de guidage multimédia peut fournir une sortie d'une première application à un utilisateur et recevoir, à partir d'une seconde application, une demande pour fournir une seconde sortie de la seconde application à l'utilisateur. En réponse à la réception de la demande, l'application de guidage multimédia peut déterminer si l'utilisateur est impliqué dans l'activité physique et, en réponse à la détermination que l'utilisateur participe à une activité physique, récupérer à partir d'une base de données des informations dans un profil correspondant à l'utilisateur. Si les informations indiquent que l'activité physique est routinière, l'application de guidage multimédia peut refuser la demande et continuer à fournir la première sortie de la première application à l'utilisateur.
Patent CA-3052504-A1 (CA)
Title: Production of liquid hydrocarbons, biofuels and uncontaminated co2 from gaseous feedstock
Inventor: WEEDON MICHAEL
IPC: C10G2/00
Filed: 2017-02-03
Abstract: There is provided a method for producing hydrocarbon compounds. The method comprising: producing a syngas by introducing a fuel stream comprising a reformable fuel into a reforming system (steam reformer, autothermal reformer, cold plasma reformer and/or internal-reforming fuel cell), and wherein the syngas comprises H2, CO and CO2, and has a ratio of [H2]/[CO] of about 1.4 to about 2.5; producing a decarbonated and dehydrated syngas from the syngas having a ratio of [CO2]/[CO + CO2] of no higher than 0.6; performing a Fischer-Tropsch synthesis on the decarbonated and dehydrated syngas in the presence of a cobalt- or iron-based Fischer- Tropsch catalyst, said Fischer-Tropsch catalyst comprising pellets of trilobe, cylindrical, hollow cylinder or spherical construction with diameter about 0.5 mm to about 3.0 mm and aspect ratio of 1 to 3.5, to produce a product stream comprising the hydrocarbon compounds; and recycling aqueous products and/or tail gas.
Patent CA-3056168-A1 (CA)
Title: Procede de fabrication d'un composant de protection contre la corrosion pour un fluide antigel
Inventor: VAUTRAVERS NICOLAS
IPC: C23F11/12
Filed: 2018-03-06
Abstract: L'invention concerne un procédé de fabrication d'un composant de protection contre la corrosion pour un fluide antigel par oxydation d'un oxydiol (I) dans lequel x représente 0 (zéro) ou un nombre entier positif compris entre 1 et 10, avec de l'oxygène moléculaire à une température comprise entre 20 et 100 °C et à une pression partielle d'oxygène comprise entre 0,01 et 2 MPa en présence d'eau et d'un catalyseur hétérogène, lequel contient du platine, par constitution d'un acide oxydicarbonique (II) dans lequel y représente 0 (zéro) ou un nombre entier positif compris entre 1 et 10, tel que l'on met en uvre l'oxydation selon un ratio molaire de 0,002 = n(Pt) / [n(oxydiol (l)) + n(acide oxydicarbonique (ll))] = 0,019 où « n(Pt) » représente la quantité molaire de platine, « n(oxydiol (I)) » représente la quantité molaire d'oxydiol (I) et « n(acide oxydicarbonique (II)) » représente la quantité molaire d'acide oxydicarbonique (II) ; à une concentration en eau comprise entre 50 et 95 % en poids dans la phase liquide ; et (c) à un pH compris entre 1 et 7.
Patent CA-3059770-A1 (CA)
Title: L-cysteine-treated proteins with altered functionalities and preparation thereof
Inventor: MANINGAT CLODUALDO C
IPC: A23J3/18
Filed: 2018-04-12
Abstract: High-protein food additives are prepared by reacting a protein material with L- cysteine, or a derivative thereof, with homogenization and heating. The homogenization and heating is preferably carried out on an aqueously slurry of the protein material and L- cysteine. The homogenized and reacted slurry is then dried to form a powder. The resultant food additive may be incorporated into a wide variety of food products to enhance the physical characteristics thereof.
Patent CA-3062740-A1 (CA)
Title: Image projection system
Inventor: GREENBERG BORIS
IPC: G02B27/01
Filed: 2017-05-29
Abstract: A system and method for retinal image projection are disclosed. The system includes an image projection module that is configured and operable for projecting at least first and second image portions corresponding respectively to first and second parts of an image to be respectively projected on foveal and peripheral regions of an eye retina; and an optical multiplexing module optically coupled to the image projection module and configured and operable to spatially and/or temporally combine/multiplex the projections of the at least first and second image portions for generating a combined image projection output for propagation along a general common optical path which is to be directed towards said eye retina. The optical multiplexing module is configured and operable to multiplex the projections the first and second image portions such that a lateral extent of the combined projection is somewhat similar to a lateral extent of the second image portion in the combined projection which is intended to fall/cover the parafoveal regions of the eye retina, and the lateral extent of the first image portion in the combined projection being smaller and within the lateral extent of the combined projection. The first and second image portions may be projected with different qualities (different resolutions and/or different color depth) and/or with different framerates in accordance with the respective foveal and parafoveally regions of the retina to which there are intended, to the by optimize the image quality/frame rate, and the associated processing and projection capabilities to the anatomical structure of the retina.
Patent CA-3064129-A1 (CA)
Inventor: STANG JONATHAN M
IPC: E21B37/00
Filed: 2019-12-06
Abstract: A clean-out tool and method of cleaning out a wellbore. The clean-out tool is placed at the end of a coiled tubing or other conveyance string. The clean-out tool comprises a tubular housing providing an elongated bore through which fluid flows. The tubular housing has back-jetting ports disposed at an upward angle therein. The clean-out tool is configured to operate in a back-jetting mode when the clean-out fluid is pumped into the tubular housing at a first flow rate. In this mode, at least a portion of clean-out fluid flows through the bore, up an annular region and then through the back jetting ports. The clean-out tool is further configured to operate in a fluid flow-through mode when the clean-out fluids are pumped into the bore of the tubular housing at a second flow rate. In this mode, all of the clean-out fluid flows through the clean-out tool.
Patent CA-3066709-A1 (CA)
Title: Battery-powered percussive massage device
Inventor: MARTON ROBERT
IPC: A61H23/00
Filed: 2018-09-28
Abstract: A percussive massage device (100) includes an enclosure having a cylindrical bore that extends along a longitudinal axis (116). A motor (310) has a rotatable shaft (312) that rotates about a central axis perpendicular to the longitudinal axis. A crank (360) coupled to the shaft includes a pivot (370), which is offset from the central axis of the shaft. A transfer bracket (510) has a first end portion coupled to the pivot of the crank. A flexible transfer linkage (512) has a first end coupled to a second end portion of the transfer bracket.  A  piston (514) has a first end coupled to a second end of the transfer linkage.  The piston is constrained to move within a cylinder along the longitudinal axis of the cylindrical bore. An applicator head (516) has a first end coupled to a second end of the piston and has a second end exposed outside the cylindrical bore for application to a person receiving treatment.
Patent CA-3068196-A1 (CA)
Title: Ror1 antibodies
Inventor: NATHWANI AMIT
IPC: C07K16/28
Filed: 2018-07-05
Abstract: Thereis described Receptor Tyrosine Kinase Like Orphan Receptor 1 (ROR1) antibodies that specifically bind a ROR1polypeptide, and their use. In particular, isolated monoclonal antibodies are described and their use in a number of applications, including in the detection, prevention and treatment of cancer.
Patent CA-3069354-A1 (CA)
Title: Solenoid pump
Inventor: LANDACRE BRETT
IPC: F04B53/22
Filed: 2020-01-22
Abstract: A solenoid pump that includes a base and a solenoid having a coil and a pole piece. A retainer body, positioned inside the solenoid and the base, includes an armature cavity that receives an armature in a sliding fit for movement between energized and de-energized positions. A diaphragm, mounted in the armature cavity, is connected to the armature. An inlet check valve permits fluid flow in only a first direction moving from an inlet port toward the diaphragm. An outlet check valve permits fluid flow in only a second direction moving from the diaphragm toward an outlet port. A  fluid flow path extends through the retainer body from the inlet check valve to the diaphragm and from the diaphragm to the outlet check valve for transporting fluid from the inlet check valve to the outlet check valve as the diaphragm oscillates between first and second positions.
Patent CA-3069849-A1 (CA)
Title: Providing pipelaying guidance
Inventor: DUNN JAMES
IPC: B66C23/36
Filed: 2020-01-27
Abstract: A device for providing pipelaying guidance is disclosed. The device may determine an original shape of a pipeline that comprises a plurality of pipeline segments. The device may obtain current location data concerning a respective position of each pipeline segment of the plurality of pipeline segments, and may determine a current shape of the pipeline based on the current location data. The device may calculate, based on the original shape of the pipeline and the current shape of the pipeline, stress information concerning the pipeline, and may perform one or more actions based on the stress information.
Patent CA-3070172-A1 (CA)
Inventor: LIGHT WILLIAM RICHARD
IPC: A61P7/08
Filed: 2018-07-17
Abstract: Methods for making hemoglobin based blood substitute preparations and hemoglobin based blood substitute preparations. The methods involve preparing a low purity erythrocyte protein fraction comprising hemoglobin protein and endogenous non-hemoglobin protein complement, and chemically modifying the proteins in the protein fraction to form a cross-linked hemoglobin containing blood substitute preparation. The low purity erythrocyte protein preparation can contain from at least about 0.2% (mole/mole) up to about 20% (mole/mole) endogenous non-hemoglobin protein complement. At least about 90% (mole/mole) of the hemoglobin proteins can be cross-linked, so that the average molecular mass of cross-linked proteins comprising hemoglobin protein molecules in the preparation is at least about 300 kDa. The preparations can be used to prepare finished blood substitute formulations for in-vivo and ex-vivo use.
Patent CA-3070535-A1 (CA)
Inventor: KASIM MUHAMMAD FIRMANSYAH
IPC: G01J3/28
Filed: 2018-07-23
Abstract: An imaging spectrometer (100) is provided, comprising: an entrance opening (101) configured to admit light to the spectrometer (100), a coded aperture (120), at least one dispersive element (111, 112), a two-dimensional array detector (130), and a plurality of converging optical elements (121, 122, 123, 124). The plurality of converging optical elements (121, 122, 123, 124) are configured to focus light from the entrance opening (101) at the coded aperture (120), and to focus light from the coded aperture (120) at the detector (130). The coded aperture (120) is arranged to modulate light from the entrance opening (101) in at least one of the spatial and spectral domain. The at least one dispersive element (111, 112) comprises a dispersive element (111, 112) between the coded aperture (120) and the detector (130). The at least one converging optical element (121, 122, 123, 124) comprises at least one concave reflector.
Patent CA-3072640-A1 (CA)
Title: Compositions, methods and systems for removal of starch
Inventor: LITERSKI GEOFFREY GRANT
IPC: B08B3/00
Filed: 2019-05-13
Abstract: The present invention is directed to compositions, methods and systems for the removal of starch. The methods include: providing cleaning solution and rinsing fluid along supply line(s); connecting the supply line(s) to one or more cleaning applicators positioned to apply the cleaning solution or the rinsing fluid to one or more surfaces of a starch applicator system; and providing a controller which is able to control application of the cleaning solution and the rinsing fluid through the one or more cleaning applicators. The systems include the components described in relation to the methods. The compositions include about 5 to 15% w/w alpha amylase to break down the starch into water-soluble units; and non-ionic surfactant(s) and/or solvent(s) to react at the interface of the starch and surface it is attached to as well as liquify the resins.
Patent CA-3072683-A1 (CA)
Inventor: YAN MAO
IPC: H04W72/04
Filed: 2018-08-02
Abstract: La présente invention concerne un procédé d'émission de signal. Le procédé peut comprendre les étapes suivantes : un terminal acquiert des premiers paramètres de configuration ; le terminal détermine, sur la base des premiers paramètres de configuration, une ressource d'accès aléatoire utilisée pour une retransmission de préambule d'accès aléatoire parmi des ressources d'accès aléatoire respectivement associées à une pluralité de signaux de liaison descendante ; et le terminal utilise la ressource d'accès aléatoire utilisée pour la retransmission de préambule d'accès aléatoire pour retransmettre un préambule d'accès aléatoire. La solution de l'invention peut augmenter le taux de réussite d'une retransmission de préambule et réduire le retard.
Patent CA-3072827-A1 (CA)
Title: Shroud segment assembly intersegment end gaps control
Inventor: LEFEBVRE GUY
IPC: F01D9/04
Filed: 2020-02-17
Abstract: An annular shroud assembly for a gas turbine engine is provided. The annular shroud assembly includes a plurality of first shroud segments having a same first arcuate length within a tolerance, at least one second shroud segment having a second arcuate length different than the first arcuate length and outside the tolerance, a plurality of first intersegment gaps between adjacent first segments, the first intersegment gaps having a circumferential dimension within a desired controlled range of dimensions, and at least two second intersegment gaps between opposed ends of the second segment and adjacent first segment. The first and second intersegment gaps are within the desired controlled range. Methods for controlling intersegment gaps between a plurality of shroud segments forming an annular shroud assembly and for forming such annular shroud assembly are also provided.
Patent CA-3072962-A1 (CA)
Inventor: BLAINE FREDRICK ALLAN
IPC: G01N1/20
Filed: 2018-08-31
Abstract: L'invention concerne un système de recueil d'échantillons pour recueillir des sous-échantillons provenant d'un flux de matière, le système comprenant un agencement de vanne et un diviseur à cône statique, l'agencement de vanne étant conçu pour permettre le fonctionnement du diviseur à cône statique en vue du recueil d'un échantillon non biaisé du flux de matière alimentant le diviseur à cône statique sous une première et une seconde condition de fonctionnement. La première condition de fonctionnement requiert que le flux de matière soit à une pression sensiblement atmosphérique et s'écoule à un débit fonctionnel minimal, et la seconde condition de fonctionnement requiert que le flux de matière soit mis sous pression à une valeur supérieure à la pression atmosphérique et présente un débit supérieur au débit fonctionnel minimal. L'invention concerne également un diviseur à cône statique s'utilisant avec le système, conjointement avec un élément conique s'utilisant avec le diviseur à cône statique.
Patent CA-3073441-A1 (CA)
Inventor: WHITE JOHNATHAN GEORGE
IPC: H04L12/22
Filed: 2020-02-24
Abstract: A method at a network element for attestation of applications, the method including sending a challenge to an application at an electronic device; receiving a response from the electronic device; processing the response; and upon determining that the response is invalid based on the processing, taking an enforcement action against the application.
Patent CA-3073824-A1 (CA)
Inventor: ZENG QINGGANG
IPC: A61F2/24
Filed: 2018-09-06
Abstract: The invention is a prosthetic device for improving function of a mitral valve.  The device includes an adjustable and axisymmetrical-or-elongated sealing member configured for positioning between mitral valve leaflets. The device also includes an expandable anchor frame configured to be positioned within one or more heart chambers, for maintaining the sealing member at a desired position and size/shape between valve leaflets. The sealing member reduces mitral regurgitation be filling the gap that can occur between opposing leaflets of a damaged mitral valve, thus restoring proper mitral valve closure.
Patent CA-3074901-A1 (CA)
Title: Modele d'organoide tumoral
Inventor: KNOBLICH JURGEN
IPC: C12N5/09
Filed: 2018-09-11
Abstract: L'invention concerne un procédé de génération d'une culture tissulaire 3D artificielle d'un cancer cultivé dans un tissu non cancéreux, comprenant les étapes consistant à fournir un agrégat de cellules souches pluripotentes ou de cellules progénitrices, cultiver et expanser lesdites cellules dans une matrice biocompatible 3D, les cellules étant autorisées à se différencier pour développer l'agrégat dans une culture tissulaire d'une taille souhaitée ; au moins une partie desdites cellules étant soumises à une cancérogenèse par expression d'un oncogène et/ou par suppression d'un gène suppresseur de tumeur pendant l'une quelconque desdites étapes ou dans la culture tissulaire, et comprenant en outre l'étape consistant à permettre auxdites cellules avec un oncogène exprimé ou un suppresseur de tumeur supprimé de se développer dans des cellules cancéreuses ; des procédés de criblage de médicaments ; des procédés de criblage de virus oncolytiques ; une culture tissulaire 3D ; et un kit pour mettre en oeuvre les procédés de l'invention.
Patent CA-3083760-A1 (CA)
Title: Aptamere anti-chymase, et son utilisation
Inventor: YAMAZAKI SATOKO
IPC: A61P13/08
Filed: 2018-11-30
Abstract: La présente invention concerne un aptamère qui se lie à une chymase et comprend une séquence consensus représentée par UAACR1N1R2GGGG (sous réserve que l'uracile puisse être la thymine). (Dans La formule, R1 et R2 représentent des bases simples arbitraires, et N1 représente de 3 à 30 bases).
Patent CA-3083881-A1 (CA)
Inventor: BAUCHE CECILE
IPC: C12N15/86
Filed: 2017-11-28
Abstract: Viral vectors are provided for use as genetic immunotherapeutic agents, including preventive and therapeutic vaccines as well as compositions to enhance cellular immune responses. The vectors are particularly useful for treating or preventing cancer and infectious diseases. The vectors include lentiviral vectors that encode one or more antigens and an adjuvant, and optionally may encode one or more soluble checkpoint inhibitor molecules. The adjuvant is a fusion protein including latent membrane protein 1 (LMPl) from Epstein Barr virus with in which the intracytoplasmic domain has been replaced by human IPSl or a variant thereof capable of activating the STING pathway. The vector-encoded sequences are codon optimized for human expression.
Patent CA-3084925-A1 (CA)
Inventor: WEBB CYNTHIA CHAFFIN
IPC: F01N3/20
Filed: 2020-06-26
Abstract: Methods of improving SCR performance in heavy duty vehicles may use multiple interdependent control techniques to increase engine exhaust temperatures in a fuel efficient manner. One method combines cylinder deactivation and mechanical loading of an engine by an electrical generator used to input energy into an exhaust stream to manipulate the exhaust temperature through the combined effect of modified air-to-fuel ratio and supplemental energy input. In particular, cylinder deactivation may be used to modify the engine air flowrate and the electric generator may be used to apply mechanical load on the engine to manipulate the engine fuel flow rate to control the engine air-to-fuel ratio and thereby increase exhaust temperatures.  The exhaust temperatures may be further increased by using the electrical generator to add the energy generated as input energy to the exhaust stream.
Patent CA-3088018-A1 (CA)
Title: Systeme et procede de vapeur separe dans une installation de production d`hydrogene
Inventor: PENG XIANG-DONG
IPC: C01B3/32
Filed: 2020-07-27
Abstract: Un circuit de vapeur séparée et un procédé dans une installation de production dhydrogène sont décrits, une eau de chaudière étant chauffée par léchange de chaleur indirect avec un reformat, leau chauffée étant utilisée pour chauffer un condensat deau formé du reformat, le condensat étant transféré à un premier collecteur de vapeur pour la production de vapeur pour un mélange de gaz dalimentation reformant et une deuxième partie de leau de chaudière chauffée étant transférée à un deuxième collecteur de vapeur pour produire une vapeur à exporter.
Patent CA-3090795-A1 (CA)
Title: Expansion of tumor infiltrating lymphocytes (tils) with adenosine a2a receptor antagonists and therapeutic combinations of tils and adenosine a2a receptor antagonists
Inventor: FARDIS MARIA
IPC: C12N5/0783
Filed: 2019-02-12
Abstract: Methods of expanding tumor infiltrating lymphocytes (TILs) in the presence of an adenosine A2A receptor (A2aR) antagonist, such as vipadenant, CPI-444 (ciforadenant), SCH58261, SYN115, ZM241385, SCH420814, a xanthine superfamily A2aR antagonist, or related adenosine receptor 2A antagonist, and uses of expanded TILs in the treatment of diseases such as cancer are disclosed herein. In addition, therapeutic combinations of TILs and A2aR antagonists, including compositions and uses thereof in the treatment of diseases such as cancer are disclosed herein.